SCHEMBL2717477

SCHEMBL2717477

Fc1ccc2nc(CCCl)c(-c3ccccn3)cc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CBFB Q13951 2/20 0.44
METAP2 P50579 1/20 0.44
METAP1 P53582 1/20 0.44
PIK3CD O00329 1/20 0.42
PIK3CG P48736 1/20 0.42
CASP6 P55212 1/20 0.39
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
SLC2A1 P11166 1/20 0.37
GRM5 P41594 3/20 0.36
TGFBR1 P36897 2/20 0.36
MAPK14 Q16539 1/20 0.36
NPY5R Q15761 1/20 0.35
CCR1 P32246 1/20 0.35
CCR5 P51681 1/20 0.35
CCR8 P51685 1/20 0.35
FFAR1 O14842 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2717418 0.87 CBFB (0.44) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL2717145 0.87 CBFB (0.44) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL3805286 0.84 METAP2 (0.46) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL2717695 0.82 CBFB (0.44) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL2717781 0.78 PIK3CD (0.40) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL2717655 0.77 PIK3CD (0.38) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL22238047 0.77 METAP2 (0.49) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL2717528 0.76 PIK3CD (0.45) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL2717476 0.74 PIK3CD (0.56) CBFBMETAP2METAP1PIK3CDPIK3CG
SCHEMBL20067937 0.74 PIK3CD (0.58) CBFBMETAP2METAP1PIK3CDPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445900-A2 POLYCYCLIC DERIVATIVES OF PYRIDINE AND THEIR USE IN THE TREATMENT OF (INTER ALIA) RHEUMATOID ARTHRITIS AND SIMILAR DISEASES Amgen, Inc (US) 2012-05-02 EP disclosed
WO-2010151740-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2010-12-29 WO disclosed